{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T15:06:02Z","timestamp":1789139162477,"version":"build-2803163510"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,5]]},"abstract":"<jats:sec>\n                    <jats:title>BACKGROUND:<\/jats:title>\n                    <jats:p>Sugammadex is used to reverse the effects of neuromuscular blocking agents in many cases of general anesthesia. However, there are several reports of anaphylaxis after its use. Skin testing is the gold standard for detecting the causative agent of anaphylaxis. However, due to the lack of validated protocols for skin testing with sugammadex, the diagnostic accuracy might be inadequate. Recently, the basophil activation test (BAT) has been established as a tool to detect the causative agent of anaphylaxis with high sensitivity and specificity. However, few studies have investigated the utility of the BAT for sugammadex-induced anaphylaxis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS:<\/jats:title>\n                    <jats:p>\n                      Eight patients who presented with immediate hypersensitivity to sugammadex during general anesthesia were included in this study. We conducted skin tests to confirm the diagnosis of sugammadex-induced anaphylaxis. Twenty-one sugammadex-naive individuals who had a negative skin test for allergy to this drug were enrolled as controls. Basophils were selected on a CD3\n                      <jats:sup>\u2212<\/jats:sup>\n                      \/CRTH2\n                      <jats:sup>+<\/jats:sup>\n                      gate and labeled with CD63 and CD203c.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>\n                      The ratios of activated basophils in the patients were much higher than those in controls: the median values of areas under the curves in the patients and controls for CD203c were 1,265,985 (95% confidence interval [CI], 77,580\u20135,040,270) and 116,325 (95% CI, \u2212268,605 to 232,690), respectively (Mann-Whitney\n                      <jats:italic toggle=\"yes\">U<\/jats:italic>\n                      test,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; .01), and the areas under the curves in the patients and controls for CD63 were 788,647 (95% CI, 120,285\u20133,523,410) and 220,005 (95% CI, \u221250,346 to 404,680), respectively (Mann-Whitney\n                      <jats:italic toggle=\"yes\">U<\/jats:italic>\n                      test,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; .01). The patients, but not controls, demonstrated clear dose-dependent CD203c upregulation. This was also true for CD63. In the case of CD203c, the sensitivity of the BAT for sugammadex was 88% (95% CI, 47%\u2013100%), and specificity was 100% (95% CI, 84%\u2013100%), while sensitivity and specificity for CD63 were 75% (95% CI, 35%\u201397%) and 100% (95% CI, 84%\u2013100%), respectively.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS:<\/jats:title>\n                    <jats:p>The BAT seems to have comparable accuracy to skin tests for the diagnosis of sugammadex-induced anaphylaxis. For this purpose, both CD203c and CD63 can be used to detect activated basophils.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1213\/ane.0000000000002879","type":"journal-article","created":{"date-parts":[[2018,3,7]],"date-time":"2018-03-07T10:39:00Z","timestamp":1520419140000},"page":"1509-1516","source":"Crossref","is-referenced-by-count":30,"title":["Usefulness of Basophil Activation Tests for Diagnosis of Sugammadex-Induced Anaphylaxis"],"prefix":"10.1213","volume":"126","author":[{"given":"Tatsuo","family":"Horiuchi","sequence":"first","affiliation":[{"name":"Department of Anesthesiology, Gunma University Graduate School of Medicine, Maebashi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiko","family":"Yokohama","sequence":"additional","affiliation":[{"name":"Division of Blood Transfusion Service, Faculty of Medicine, Gunma University Hospital, Maebashi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaki","family":"Orihara","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Gunma University Graduate School of Medicine, Maebashi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukinari","family":"Tomita","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Isesaki Municipal Hospital, Isesaki, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiro","family":"Tomioka","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Gunma Central Hospital, Maebashi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nagahide","family":"Yoshida","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Saiseikai Maebashi Hospital, Maebashi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichiro","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Ashikaga Red Cross Hospital, Ashikaga, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeru","family":"Saito","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Gunma University Graduate School of Medicine, Maebashi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomonori","family":"Takazawa","sequence":"additional","affiliation":[{"name":"Intensive Care Unit, Gunma University Hospital, Maebashi, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230721","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1213\/01.ane.0000244594.63318.fc","article-title":"Sugammadex: another milestone in clinical neuromuscular pharmacology.","volume":"104","author":"Naguib","year":"2007","journal-title":"Anesth Analg"},{"key":"R2-20230721","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1007\/s00540-015-2105-x","article-title":"Sugammadex and rocuronium-induced anaphylaxis.","volume":"30","author":"Takazawa","year":"2016","journal-title":"J Anesth"},{"key":"R3-20230721","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.anai.2016.09.428","article-title":"Sugammadex: an emerging trigger of intraoperative anaphylaxis.","volume":"117","author":"Ue","year":"2016","journal-title":"Ann Allergy Asthma Immunol"},{"key":"R4-20230721","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1111\/anae.12736","article-title":"Hypersensitivity associated with sugammadex administration: a systematic review.","volume":"69","author":"Tsur","year":"2014","journal-title":"Anaesthesia"},{"key":"R5-20230721","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/1471-2253-14-92","article-title":"Three suspected cases of sugammadex-induced anaphylactic shock.","volume":"14","author":"Takazawa","year":"2014","journal-title":"BMC Anesthesiol"},{"key":"R6-20230721","first-page":"103","article-title":"In vitro diagnosis of immediate allergic reactions to drugs: an update.","volume":"20","author":"Mayorga","year":"2010","journal-title":"J Investig Allergol Clin Immunol"},{"key":"R7-20230721","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1177\/0310057X1404200116","article-title":"Intraoperative anaphylaxis to sugammadex and a protocol for intradermal skin testing.","volume":"42","author":"Sadleir","year":"2014","journal-title":"Anaesth Intensive Care"},{"key":"R8-20230721","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1111\/j.1399-6576.2007.01313.x","article-title":"Scandinavian clinical practice guidelines on the diagnosis, management and follow-up of anaphylaxis during anaesthesia.","volume":"51","author":"Kroigaard","year":"2007","journal-title":"Acta Anaesthesiol Scand"},{"key":"R9-20230721","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1365-2044.2008.05733.x","article-title":"Suspected anaphylactic reactions associated with anaesthesia.","volume":"64","author":"Harper","year":"2009","journal-title":"Anaesthesia"},{"key":"R10-20230721","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1111\/j.1398-9995.2006.01094.x","article-title":"Flow-assisted diagnostic management of anaphylaxis from rocuronium bromide.","volume":"61","author":"Ebo","year":"2006","journal-title":"Allergy"},{"key":"R11-20230721","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1111\/all.12468","article-title":"Flowcytometric diagnosis of atracurium-induced anaphylaxis.","volume":"69","author":"Uyttebroek","year":"2014","journal-title":"Allergy"},{"key":"R12-20230721","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/j.1365-2044.2004.04086.x","article-title":"Flow cytometric investigation of peri-anaesthetic anaphylaxis using CD63 and CD203c.","volume":"60","author":"Sudheer","year":"2005","journal-title":"Anaesthesia"},{"key":"R13-20230721","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1111\/j.1365-2222.2008.02960.x","article-title":"Comparison of two basophil activation markers CD63 and CD203c in the diagnosis of amoxicillin allergy.","volume":"38","author":"Abuaf","year":"2008","journal-title":"Clin Exp Allergy"},{"key":"R14-20230721","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/17843286.2015.1122871","article-title":"Flow-assisted basophil activation tests in immediate drug hypersensitivity: two decades of Antwerp experience.","volume":"71","author":"Mangodt","year":"2016","journal-title":"Acta Clin Belg"},{"key":"R15-20230721","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1111\/all.12698","article-title":"The clinical utility of basophil activation testing in diagnosis and monitoring of allergic disease.","volume":"70","author":"Hoffmann","year":"2015","journal-title":"Allergy"},{"key":"R16-20230721","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1093\/bja\/aev093","article-title":"Flow cytometric investigation of sugammadex-induced anaphylaxis.","volume":"114","author":"Takazawa","year":"2015","journal-title":"Br J Anaesth"},{"key":"R17-20230721","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1111\/all.12142","article-title":"Skin test concentrations for systemically administered drugs\u2014an ENDA\/EAACI Drug Allergy Interest Group position paper.","volume":"68","author":"Brockow","year":"2013","journal-title":"Allergy"},{"key":"R18-20230721","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1046\/j.0105-4538.2001.00001.x-i8","article-title":"General considerations for skin test procedures in the diagnosis of drug hypersensitivity.","volume":"57","author":"Brockow","year":"2002","journal-title":"Allergy"},{"key":"R19-20230721","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1034\/j.1600-0536.2001.450601.x","article-title":"Guidelines for performing skin tests with drugs in the investigation of cutaneous adverse drug reactions.","volume":"45","author":"Barbaud","year":"2001","journal-title":"Contact Dermatitis"},{"key":"R20-20230721","first-page":"442","article-title":"Reducing the risk of anaphylaxis during anesthesia: 2011 updated guidelines for clinical practice.","volume":"21","author":"Mertes","year":"2011","journal-title":"J Investig Allergol Clin Immunol"},{"key":"R21-20230721","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1002\/cyto.b.20526","article-title":"CD203c-based basophil activation test in allergy diagnosis: characteristics and differences to CD63 upregulation.","volume":"78","author":"Sturm","year":"2010","journal-title":"Cytometry B Clin Cytom"},{"key":"R22-20230721","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.jaci.2005.12.1303","article-title":"Second symposium on the definition and management of anaphylaxis: summary report\u2013Second National Institute of Allergy and Infectious Disease\/Food Allergy and Anaphylaxis Network symposium.","volume":"117","author":"Sampson","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"R23-20230721","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1111\/all.12437","article-title":"Anaphylaxis: guidelines from the European Academy of Allergy and Clinical Immunology.","volume":"69","author":"Muraro","year":"2014","journal-title":"Allergy"},{"key":"R24-20230721","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.alit.2016.02.013","article-title":"Anaphylaxis caused by \u03b3-cyclodextrin in sugammadex.","volume":"65","author":"Hotta","year":"2016","journal-title":"Allergol Int"},{"key":"R25-20230721","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0167-5877(00)00115-X","article-title":"Principles and practical application of the receiver-operating characteristic analysis for diagnostic tests.","volume":"45","author":"Greiner","year":"2000","journal-title":"Prev Vet Med"},{"key":"R26-20230721","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1159\/000222678","article-title":"Upregulation of CD63 or CD203c alone or in combination is not sensitive in the diagnosis of nonsteroidal anti-inflammatory drug intolerance.","volume":"150","author":"Bavbek","year":"2009","journal-title":"Int Arch Allergy Immunol"},{"key":"R27-20230721","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1046\/j.1365-2222.2003.00691.x","article-title":"Comments regarding \u2018Marked improvement of the basophil activation test by detecting CD203c instead of CD63\u2019 by Boumiza et al.","volume":"33","author":"Ebo","year":"2003","journal-title":"Clin Exp Allergy"},{"key":"R28-20230721","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1046\/j.1365-2222.2003.01594.x","article-title":"Marked improvement of the basophil activation test by detecting CD203c instead of CD63.","volume":"33","author":"Boumiza","year":"2003","journal-title":"Clin Exp Allergy"},{"key":"R29-20230721","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1398-9995.2006.00978.x","article-title":"Diagnosis of neuromuscular blocking agent hypersensitivity reactions using cytofluorimetric analysis of basophils.","volume":"61","author":"Kvedariene","year":"2006","journal-title":"Allergy"},{"key":"R30-20230721","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/j.1398-9995.2008.01713.x","article-title":"Negativization rates of IgE radioimmunoassay and basophil activation test in immediate reactions to penicillins.","volume":"64","author":"Fern\u00e1ndez","year":"2009","journal-title":"Allergy"}],"container-title":["Anesthesia &amp; Analgesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00000539-201805000-00019","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T14:19:08Z","timestamp":1786112348000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00000539-201805000-00019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1213\/ane.0000000000002879","relation":{},"ISSN":["0003-2999"],"issn-type":[{"value":"0003-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]}}}